Companies Hit $1B in Investment
The 10-year total investment in the 102 member companies since opening the VDC in 2009 has reached $1,001,972,265. The companies have a headcount of 1,128. The 132 investors in the companies include 5 of the world’s top 10 venture capital firms. 38 of the 102 companies account for 98% of the total funds raised. Of those 38, 97% are active and growing. 84% of these companies have at least one foreign-born founder who graduated from a university in the US and decided to move to or remain in Boston to launch a company.
The largest financing round was the August 8, 2018 $72M Series C announced by SQZ Biotech. On October 15, 2018, Roche committed an additional $125 million in upfront and near-term payments to expand its partnership with SQZ. Other notable financial milestones are the S&P Global acquisition on March 6, 2018 of Kensho for $550M; and the June 28, 2018 acquisition by Amazon of PillPack for $1B.
Stories Behind the Results
SQZ Biotech: Building a fast growing company.
Polaris Partner and a former Pfizer exec Amy Schulman bet on cell therapy company SQZ Biotech because of Armon Sharei, even though he’s young and had never started a company before. “For somebody as smart as he is, he’s really humble and he’s eager to learn.”
Armon picked the VDC to launch the company out of the MIT Langer Lab. In 18 months, SQZ grew to 30 employees, and landed a $500M deal with Roche. Today it has 85 employees.
“The VDC offers an excellent environment in which to build our company. The staff are phenomenal in their commitment to culture and understanding of the unique needs of a startup. And we are inspired by all the innovative work our neighbors in the space are doing.”
Visit SQZ Biotech
PillPack: Rescuing the rockstar software engineer.
PillPack pre-sorts drugs into daily regimens and ships them to customers nationwide, relieving the burden of managing medications. Well before it became a $1 billion Amazon acquisition, we facilitated a visa that kept an engineer of the backend pharmacy system in Boston.
We worked with PillPack’s attorneys to file a cap-exempt H-1B petition, which was approved. While in residence at the VDC, she contributed to making the Introduction to Software Engineering course more current and relevant to the real-world. PillPack eventually won its own visa for her independent of UMass.
According to Matt Pokress, PillPack’s VP for Engineering: “Wouldn’t have been able to do it without this team – and she continues to be a huge contributor to our success.”
Platelet Biogenesis: Delivering mission critical core research facilities.
This spinout from Brigham and Women’s Hospital needed private laboratories to build its team and access to animal and imaging facilities. The company grew from 5 to 20 employees at the VDC. And it landed a $10 million Series A investment from Qiming Venture Partners to support preclinical testing of its bioreactor which permits the production of blood cells for transfusion therapy.
Even after graduating to larger facilities, Platelet BioGenesis scientists continue to use the animal facility and confocal microscope. According to Lea Beaulieu, Platelet’s Associate Director: “The UMass Boston facility has all the things we need. They want to help people meet their goals and succeed. We maintain our protocols there for these reasons and will continue to as we expand.”
Visit Platelet Biogenesis
CloudHealth Technologies: Starting out with a team of talented interns.
Kleiner Perkins backed CloudHealth Technologies was formed while the co-founder, Dan Phillips, was an Entrepreneur-in-Residence at the VDC. The idea behind CloudHealth is to help businesses manage their entire cloud ecosystem. The company’s approach has won it more than 3,000 customers.
To start out, Phillips brought on a UMass Boston intern, Livja Jaho. According to her, “When I was a student, I became the third person to join the CloudHealth team.” Phillips adds: “UMass Boston students are exactly the type I like to hire at my companies. They can handle adversity, want ownership, and require and expect little supervision. They have been exceptional.”
VMWare recently acquired the 250-person company for $530 million in cash. After the acquisition, Phillips returned to UMass Boston to create a scholarship and mentoring program for students.
Visit CloudHealth Technologies